{"DataElement":{"publicId":"6740601","version":"1","preferredName":"Gross Tumor Residual Remaining Pathology Residual Disease Type","preferredDefinition":"Information relating to gross tumor residual remaining._The type of residual disease that remains","longName":"2200386v1.0:6740599v1.0","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"2200386","version":"1","preferredName":"Gross Tumor Residual Remaining","preferredDefinition":"Information relating to gross tumor residual remaining.","longName":"GROSS_TUM_RSDL_RMNG","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2660141","version":"1","preferredName":"Gross Neoplasm","preferredDefinition":"Visible to the naked eye.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C43566:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gross","conceptCode":"C43566","definition":"Visible to the naked eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33DA6504-051E-121A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-26","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-26","modifiedBy":"ONEDATA","dateModified":"2007-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207602","version":"1","preferredName":"Residual Remaining","preferredDefinition":"Remaining or left behind.:Remaining; enduring or persisting.","longName":"C37895:C25649","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Remaining","conceptCode":"C25649","definition":"Enduring or persisting; residual, left over or behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-29BF-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F11E1A98-D668-67E3-E034-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-03-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-03-01","modifiedBy":"TAYLORT","dateModified":"2017-08-23","changeDescription":"8/23/17 tt transferred context, added registration status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6740599","version":"1","preferredName":"Residual Disease Type","preferredDefinition":"The type of residual disease that remains","longName":"6740599v1.0","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Any gross residual disease","valueDescription":"Any gross residual disease","ValueMeaning":{"publicId":"6740600","version":"1","preferredName":"Any gross residual disease","longName":"6740600","preferredDefinition":"Any gross residual disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FF95A3-E7B4-1CE1-E053-F662850A09ED","latestVersionIndicator":"Yes","beginDate":"2019-05-03","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-05-03","modifiedBy":"ONEDATA","dateModified":"2019-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87FF95A3-E7CD-1CE1-E053-F662850A09ED","beginDate":"2019-05-03","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-05-03","modifiedBy":"ONEDATA","dateModified":"2019-05-03","deletedIndicator":"No"},{"value":"Microscopic residual disease","valueDescription":"Microscopic Residual Disease","ValueMeaning":{"publicId":"2964848","version":"1","preferredName":"Microscopic Residual Disease","longName":"2964848","preferredDefinition":"Microscopic; too small to be seen except under a microscope.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic","conceptCode":"C25252","definition":"Too small to be seen except under a microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A02CEF7-CA80-C96C-E040-BB89AD430150","latestVersionIndicator":"Yes","beginDate":"2009-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87FF95A3-E7D7-1CE1-E053-F662850A09ED","beginDate":"2019-05-03","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-05-03","modifiedBy":"ONEDATA","dateModified":"2019-05-03","deletedIndicator":"No"},{"value":"Suboptimal (greater than 1 cm)","valueDescription":"Suboptimal (greater than 1 cm)","ValueMeaning":{"publicId":"6820579","version":"1","preferredName":"Suboptimal (greater than 1 cm)","longName":"6820579","preferredDefinition":"Suboptimal (greater than 1 cm)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E49E8AE-CC4D-778F-E053-F662850A1A43","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-07-22","modifiedBy":"ONEDATA","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E49E8AE-CC66-778F-E053-F662850A1A43","beginDate":"2019-07-22","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-07-22","modifiedBy":"ONEDATA","dateModified":"2019-07-22","deletedIndicator":"No"},{"value":"Residual disease, optimal (less than or equal to 1 cm)","valueDescription":"Residual disease, optimal (less than or equal to 1 cm)","ValueMeaning":{"publicId":"6820580","version":"1","preferredName":"Residual disease, optimal (less than or equal to 1 cm)","longName":"6820580","preferredDefinition":"Residual disease, optimal (less than or equal to 1 cm)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E49E8AE-CC70-778F-E053-F662850A1A43","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-07-22","modifiedBy":"ONEDATA","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E49E8AE-CC89-778F-E053-F662850A1A43","beginDate":"2019-07-22","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-07-22","modifiedBy":"ONEDATA","dateModified":"2019-07-22","deletedIndicator":"No"},{"value":"No gross residual disease","valueDescription":"No gross residual disease","ValueMeaning":{"publicId":"6820581","version":"1","preferredName":"No gross residual disease","longName":"6820581","preferredDefinition":"No gross residual disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E49E8AE-CC93-778F-E053-F662850A1A43","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-07-22","modifiedBy":"ONEDATA","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E49E8AE-CCAC-778F-E053-F662850A1A43","beginDate":"2019-07-22","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-07-22","modifiedBy":"ONEDATA","dateModified":"2019-07-22","deletedIndicator":"No"},{"value":"Residual disease, subobtimal (greater than 1cm)","valueDescription":"Residual disease, subobtimal (greater than 1cm)","ValueMeaning":{"publicId":"7139801","version":"1","preferredName":"Residual disease, subobtimal (greater than 1cm)","longName":"7139801","preferredDefinition":"Residual disease, subobtimal (greater than 1cm)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C338EAA-5D58-51BF-E053-F662850ACB65","latestVersionIndicator":"Yes","beginDate":"2020-01-15","endDate":null,"createdBy":"SARAHB","dateCreated":"2020-01-15","modifiedBy":"ONEDATA","dateModified":"2020-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C338EAA-5D71-51BF-E053-F662850ACB65","beginDate":"2020-01-15","endDate":null,"createdBy":"SARAHB","dateCreated":"2020-01-15","modifiedBy":"ONEDATA","dateModified":"2020-01-15","deletedIndicator":"No"},{"value":"Residual disease, suboptimal (greater than 1cm)","valueDescription":"Residual disease, suboptimal (greater than 1cm)","ValueMeaning":{"publicId":"7385258","version":"1","preferredName":"Residual disease, suboptimal (greater than 1cm)","longName":"7385258","preferredDefinition":"Residual disease, suboptimal (greater than 1cm)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC87FD15-6E0C-32DB-E053-4EBD850A0CB3","latestVersionIndicator":"Yes","beginDate":"2020-08-10","endDate":null,"createdBy":"SARAHB","dateCreated":"2020-08-10","modifiedBy":"ONEDATA","dateModified":"2020-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC87FD15-6E25-32DB-E053-4EBD850A0CB3","beginDate":"2020-08-10","endDate":null,"createdBy":"SARAHB","dateCreated":"2020-08-10","modifiedBy":"ONEDATA","dateModified":"2020-08-10","deletedIndicator":"No"},{"value":"Residual disease, suboptimal (greater than 1 cm)","valueDescription":"Residual disease, suboptimal (greater than 1 cm)","ValueMeaning":{"publicId":"7385455","version":"1","preferredName":"Residual disease, suboptimal (greater than 1 cm)","longName":"7385455","preferredDefinition":"Residual disease, suboptimal (greater than 1 cm)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC9BE100-0990-30C7-E053-4EBD850ACDA2","latestVersionIndicator":"Yes","beginDate":"2020-08-11","endDate":null,"createdBy":"SARAHB","dateCreated":"2020-08-11","modifiedBy":"ONEDATA","dateModified":"2020-08-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC9BE100-09A9-30C7-E053-4EBD850ACDA2","beginDate":"2020-08-11","endDate":null,"createdBy":"SARAHB","dateCreated":"2020-08-11","modifiedBy":"ONEDATA","dateModified":"2020-08-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6740598","version":"1","preferredName":"Residual Disease Type","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4809:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FF95A3-E78F-1CE1-E053-F662850A09ED","latestVersionIndicator":"Yes","beginDate":"2019-05-03","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-05-03","modifiedBy":"ONEDATA","dateModified":"2019-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FF95A3-E7A0-1CE1-E053-F662850A09ED","latestVersionIndicator":"Yes","beginDate":"2019-05-03","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-05-03","modifiedBy":"SARAHB","dateModified":"2020-08-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Following primary cytoreducti","type":"Preferred Question Text","description":"Following primary cytoreduction surgery, is the patients residual disease:","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FFA4D6-3A4E-26A8-E053-F662850ADBB8","latestVersionIndicator":"Yes","beginDate":"2019-05-03","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-05-03","modifiedBy":"TAYLORT","dateModified":"2019-08-05","changeDescription":"8-5-19 tt associated CDE with released version of DEC.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}